| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.086 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |